AzTrials
AzTrials

HypospadiasKOKNCT04142632

Long Term Follow-up for Hypospadias

An observational study of Hypospadias, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hypospadias is a frequent malformation. The definition of hypospadias is a ventral tissues hypoplasia, with an abnormal position of the urethral meatus, a chordee of the penis and an open foreskin. Read more about this study

Who is it for?
Ages 14 years and older, men only
Conditions the study is for
Hypospadias
What is being tested?
clinical and paraclinical examination
Type of treatment
Surgery or procedure
How many people
10 participants
Where
1 siteFrance
Study dates
17 Feb 2020to 28 Jan 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 years and older
  • Men only
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Male patients with previous hypospadias surgery, the intervention has to be realized before December the 31th 2005.The surgery was performed by one operator (Pr MOURIQUAND), with the following surgical technics: Koff, Onlay and Koyanagi. The patients are informed by an official surgery department letter, to assure they agree to participate. If the patient is still an infant, the parental agreement will be necessary.

Who may be able to join

  • Male patients
  • with previous hypospadias surgery,
  • Birthday before December the 31th 2009.
  • The surgery was performed by one operator, with the following surgical technics: Koff, Onlay and Koyanagi.
  • The patients are informed by an official surgery department letter, to assure they agree to participate.
  • if the patient is still an infant, the parental agreement will be necessary.

Who cannot join

  • Patient deceased
  • Non- agreement from the patient or his parents
  • Language difficulties

Trial locations and contacts

1 site in 1 country.

France1 site
  • Service de chirurgie uro-viscérale, thoracique et de transplantation de l'enfant Hôpital Femme Mère Enfant

    Bron, 69500

Other trials in France

About this study

Official title: Long Term Follow-up for Hypospadias. Hypospadias KOK

Hypospadias is a frequent malformation. The definition of hypospadias is a ventral tissues hypoplasia, with an abnormal position of the urethral meatus, a chordee of the penis and an open foreskin. It can be associate with other genital malformation; in that case it can be classified in the wider field of the disorder of sex development (DSD). There is a lot of surgical technics for those malformations.

In the pediatric surgical department, in Lyon, three technics are the most used because of their reliability and their good outcomes in short and mid term.

This is essential for investigator to have a long term evaluation, with a physical exam and paraclinical exams, after the puberty, to assess the outcomes after the changes especially at the puberty.

Conditions
Hypospadias
Being tested
clinical and paraclinical examination
Medical subject headings
Hypospadias

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • clinical and paraclinical examinationProcedure or surgery

    Physical examination of the penis, ultrasonography of the bladder end the testis, Biological sample for endocrine assessment

Study groups in NCT04142632
Study groupRoleWhat they receive
long term evaluation of hypospadias surgeryNot described
Receives: Procedure: clinical and paraclinical examination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Event Free Survival

    Time with no complication after the last surgery for hypospadias

    Measured: Day 0

Secondary outcomes (14)
  1. Penis size

    Measured: Day 0

  2. Urinary symptoms

    The investigator will do an interrogation of the patient about urinary symptoms, the response will be yes or no.

    Measured: Day 0

  3. quality of the urinary flow: straight or not straight

    Measured: Day 0

  4. occurrence of urinary infection

    Measured: Day 0

  5. sexual activity

    The investigator will do an interrogation of the patient about sexual activity, the response will be yes or no.

    Measured: Day 0

  6. occurrence of ejaculation

    Measured: Day 0

  7. occurrence of erection

    Measured: Day 0

  8. Pre-voiding bladder volume

    Measured: Day 0

  9. post-voiding bladder volume

    Measured: Day 0

  10. Flow measurement

    The investigator will use an urinary flowmeter; the investigator will collect data with a curve for each patient, with time in x-axis and ml/s in y-axis.

    Measured: Day 0

  11. Testicular ultrasonography

    The investigator will ask a testicular ultrasonography which will be performed by a radiologist, the following data will be collected: testicular volume, aspect of the testicular parenchyma.

    Measured: day 0

  12. puberty clinical signs

    The investigator will use the tanner's criteria during the physical examination.

    Stages of genital [G] and pubic hair [Ph] development in the male. G-1, Ph-1: pre-pubertal; G-2: the testis and scrotum enlarge, and the skin of the scrotum shows some reddening and change in the texture. Sparse growth of pigmented hair usually slightly curly, mainly at the base of the penis (Ph-2); G-3: Testis and scrotum enlarge further, the penis grows mainly in length but also in breadth. The hair is darker, coarser and curlier and spreads over the junction of the pubes (Ph-3); G-4: Scrotum, testis, and penis grow further with development of the glans, and further darkening of the scrotal skin. The hair spreads covering the pubes; G-5: adult stage with spreading of the hair to the medial surface of the thighs (Ph-5).

    Measured: Day 0

  13. endocrine disorder

    Measured: Day 0

  14. patient satisfaction

    The investigator will do an interrogation of the patient about his personal satisfaction, the response will be yes or no.

    Measured: day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2019
  2. Study start17 Feb 2020
  3. Primary completion28 Jan 2026
  4. Study completion28 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04142632
Sponsor's protocol ID
69HCL19_0334
Other IDs
2019-A02136-51
Acronym
KOK
Status last verified
Feb 2026
First submitted
27 Sep 2019
Last updated
13 Feb 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hypospadias, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Event Free Survival (time frame: Day 0). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in